ATTENTION NASDAQ: QURE INVESTORS: Contact Berger Montague About an uniQure N.V. Class Action Lawsuit
uniQure N.V. - Ordinary Shares (QURE)
Last uniqure n.v. - ordinary shares earnings: 4/29 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
uniqure.com/investors-newsroom/overview.php
Company Research
Source: GlobeNewswire
PHILADELPHIA, Feb. 13, 2026 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces that a class action lawsuit has been filed against uniQure N.V. (NASDAQ: QURE) (“uniQure” or the “Company”) on behalf of investors who purchased or otherwise acquired uniQure securities during the period from September 24, 2025 through October 31, 2025 (the “Class Period”). Investor Deadline: Investors who purchased uniQure securities during the Class Period may, no later than April 13, 2026, seek to be appointed as a lead plaintiff representative of the class. To learn your rights, CLICK HERE. uniQure, based in Amsterdam, develops and commercializes gene therapies for patients with severe, often life-threatening diseases, with a focus on Huntington’s disease and other neurological disorders. According to the Complaint, uniQure misled investors about the effectiveness of its gene therapy candidate AMT-130 and the likelihood of accelerated FDA approval. Defendants touted redu
Show less
Read more
Impact Snapshot
Event Time:
QURE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QURE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QURE alerts
High impacting uniQure N.V. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
QURE
News
- uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLCPR Newswire
- ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages uniQure N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action - QUREGlobeNewswire
- QURE Stockholder Alert: Robbins LLP Reminds Investors of the Class Action Against uniQure N.V.PR Newswire
- QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law FirmGlobeNewswire
- QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud LawsuitPR Newswire
QURE
Earnings
- 11/10/25 - Miss
QURE
Sec Filings
- 2/13/26 - Form SCHEDULE
- 2/9/26 - Form SCHEDULE
- 1/29/26 - Form SCHEDULE
- QURE's page on the SEC website